News & Perspective

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Jun 27, 2012

Jun 27, 2012

HHS updates medical countermeasures strategy

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently updated its strategy for developing and acquiring countermeasures against threats such as bioterror attacks and pandemic flu, a document that spells out the federal game plan for the next 5 years.

Jun 18, 2012

Jun 18, 2012

HHS launches partnerships to make biodefense products

(CIDRAP News) – US health officials today announced the establishment of three public-private centers designed to give the nation a new and stronger ability to quickly make vaccines and drugs to respond to bioterrorist attacks, pandemic influenza, and other public health emergencies.

Jul 28, 2011

Jul 28, 2011

Renewal of 2006 preparedness law advances in US House

(CIDRAP News) – The US House Energy and Commerce Committee today approved legislation to renew and fine-tune a 2006 law that has been credited with significantly improving the nation's preparedness for public health emergencies.

Sep 21, 2010

Sep 21, 2010

BARDA contracts target countermeasures, pandemic vaccine

(CIDRAP News) – Coming a month after federal officials released a blueprint for overhauling the nation's civilian biodefense program, the US Department of Health and Human Services (HHS) today announced the award of eight contracts worth up to $100 million to modernize and speed the development of countermeasures against natural and man-made disease threats.

Jun 23, 2009

Jun 23, 2009

Firm wins HHS contract for new flu vaccine technology

(CIDRAP News) – The US government has granted Protein Sciences Corp. (PSC) of Meriden, Conn., a $35 million contract to develop its technique for making influenza vaccines by growing flu virus proteins in insect cells, an approach said to be faster than traditional methods.

Pages

Narrow results

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»